In partnership with the United States Patent and Trademark Office (USPTO), NIHF will honour a total of 16 inductees on October 26, 2023, at one of the innovation industry’s most highly anticipated events - “The Greatest Celebration of American Innovation®.”
The event also will celebrate the 50th anniversary of NIHF’s founding in 1973, when Thomas Edison was the sole Inductee.
Born in Oldham and educated at Ackworth School, a Quaker boarding school, Ms Brodie went on to discover and develop a class of drugs called aromatase inhibitors, which can stop the production of hormones that fuel the growth of cancer cells.
Aromatase inhibitors are among the leading therapies against breast cancer.
Named on 13 US patents, Ms Brodie was a Fellow of the American Academy for Cancer Research (AACR), and her many awards include the Dorothy P. Landon-AACR Prize for Translational Cancer Research and the Brinker Award for Scientific Distinction from the Susan G. Komen Breast Cancer Foundation.
In 2005, Ms Brodie became the first woman to be honored with the Charles F. Kettering Prize from the General Motors Cancer Research Foundation.
She lived in America from 1962 until she died on June 7, 2017 at the age of 82 at her home in Fulton, Maryland, from complications due to Parkinson's disease.
